The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.
The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.
Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists
申请人:The Regents of the University of California
公开号:US07585868B2
公开(公告)日:2009-09-08
The present invention provides novel compounds that can be used as antagonists of a lipid kinase such as a PI3 kinase, protein tyrosine kinase, and/or protein serine-threonine kinases such as mTOR. The present invention also provides methods of using the compounds for treating various disease conditions. The compounds include those having the formula:
wherein the R1, R2 and R36 are as defined herein.
Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents
申请人:Knight Zachary A.
公开号:US08642604B2
公开(公告)日:2014-02-04
The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.
PYRAZOLOPYRMIDINE DERIVATIVES FOR USE AS PI3 KINASE ANTAGONISTS
申请人:The Regents of The University of California
公开号:EP2551270A2
公开(公告)日:2013-01-30
The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PDKinase and mTOR, or PI3Kinase, mTOR and tyrosine kinase.